Genetics and molecular pathogenesis of mitochondrial respiratory chain diseases

Cell Mol Life Sci. 1999 May;55(5):691-706. doi: 10.1007/s000180050327.

Abstract

Dysfunction of the mitochondrial respiratory chain has been recognised as a cause of human disease for over 30 years. Advances in the past 10 years have led to a better understanding of the genetics and molecular pathogenesis of many of these disorders. Over 100 primary defects in mitochondrial DNA (mtDNA) are now implicated in the pathogenesis of a group of disorders which are collectively known as the mitochondrial encephalomyopathies, and which most frequently involve skeletal muscle and/or the central nervous system. Although impaired oxidative phosphorylation is likely to be the final common pathway leading to the cellular dysfunction associated with such mtDNA mutations, the complex relationship between genotype and phenotype remains largely unexplained. Most of the genes which encode the respiratory chain reside in the nucleus, yet only five nuclear genes have been implicated in human respiratory chain diseases. There is evidence that respiratory chain dysfunction is present in common neurological diseases such as Parkinson's disease and Huntington's disease. The precise cause of this respiratory chain dysfunction and its relationship to the disease process are unclear. This review focuses upon respiratory chain disorders associated with primary defects in mtDNA.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Base Sequence
  • DNA Replication
  • DNA, Mitochondrial / genetics
  • Electron Transport / genetics*
  • Female
  • Humans
  • Male
  • Mitochondrial Encephalomyopathies / etiology*
  • Mitochondrial Encephalomyopathies / genetics*
  • Mitochondrial Encephalomyopathies / metabolism
  • Molecular Sequence Data
  • Mutation
  • Oxidative Phosphorylation
  • Phenotype
  • Protein Biosynthesis
  • Transcription, Genetic

Substances

  • DNA, Mitochondrial